T&T Scientific offers the world’s best nanomedicine manufacturing platform with scalable, low cost, high throughput, high quality, and a wide range of operations. The GMP system can operate and process 50mL to at least 500L+ (Tested) nanomedicines for cGMP manufacturing of gene therapies and vaccines (i.e., RNA therapeutics and COVID-19 vaccines). The NanoSizerTM technology has been developed over the years with great characterization and optimization procedures to achieve the precise and narrow size distribution of particles and producing highly encapsulated lipid nanoparticle APIs. We have reached the PDI as low as 0.05 and consistent encapsulation efficiency of over 99% after optimizing flow conditions for a given formulation. Moreover, the cell studies indicated a promising transfection and association of lipid nanoparticle mRNA into cells. T&T Scientific does not require any licensing and royalty fees or contracts for its clients. T&T Scientific culture believes clients should have no limitation when developing lifesaving novel pharmaceutical nanomedicine therapeutics and vaccines.